Lawsuit Update Center

TRESemmé is a popular brand of shampoo and other hair care products made by Unilever, Inc. Recently, consumers have filed lawsuits alleging that TRESemmé shampoo contains harmful chemicals such as formaldehyde that have caused users to suffer hair loss.

About Unilever and TRESemmé

Unilever is a major manufacturer of personal care products and it is the second leading manufacturer of shampoo in the world. TRESemmé is one of Unilever’s most popular hair care brands. The TRESemmé Products are sold directly by Unilever through retailers.  Unilever promotes TRESemmé Products through labeling and advertising channels, including representations written or approved by Unilever on retail websites like Walmart.

On this page we will explain who is eligible to file an Exactech implant recall lawsuit. We will summarize the basic eligibility criteria that our firm is applying to screen potential Exactech lawsuits; and we will describe the relevant injuries being alleged in the Exactech cases.

What Are the Exactech Recall Lawsuits About?

Exactech is a medical device company that specializes in making surgical implant systems for use in joint replacement surgeries such as knee, hip and ankle replacements. In August 2021, Exactech annouced a massive recall covering all of its knee and ankle replacement implants manufactured in 2004 or later.

On this page we will look at who qualifies to file a Truvada lawsuit. We will summarize the basic eligibility criteria that our firm is applying to screen potential Truvada lawsuits; and we will describe the relevant injuries being alleged in the Truvada cases.

What Are the Truvada Lawsuits About?

Truvada is a prescription drug used for the treatment and prevention of HIV. It helps to control the HIV virus and prevent it from being transmitted to partners. The active ingredient in Truvada is tenofovir disoproxil fumarate or “TDF” which was developed by Truvada’s manufacturer, Gilead Pharmaceuticals.

In 2021, the cellular wireless network company T-Mobile experienced a major “data breach” that caused the personal information of millions of their customers to be exposed to potential hackers. A class action lawsuit was filed against T-Mobile on behalf of all wireless customers who had their information exposed. That lawsuit eventually resulted in a $350 million settlement available to all impacted customers. On this page, we will explain the story behind the T-Mobile customer data breach lawsuit and outline the details of the settlement.

Following a cyberattack in 2021 that exposed the personal information of millions of customers, T-Mobile reached a settlement of $350 million to address allegations of negligence leading to the breach. This settlement marked the second-largest in U.S. history for a data breach, with Equifax’s $700 million settlement in 2019 being the largest.

The deadline for submitting claims to be part of the substantial payout was Monday, January 23, 2023. However, shortly before this deadline, on January 19, 2023, T-Mobile disclosed another cyberattack that affected a minimum of 37 million current customers.

On this page we will look at who qualifies to file a Bard PowerPort port catheter lawsuit. We will summarize the basic eligibility criteria that our firm is applying to screen potential PowerPort lawsuits; and we will describe the relevant injuries associated with the PowerPort lawsuits.

About the Bard Port Catheter Lawsuits

The Bard PowerPort, manufactured and designed by Bard Access Systems, Inc. (now a subsidiary of Becton, Dickinson and Company), is a fully implantable vascular access catheter system. This system is created to facilitate repeated access to the vascular system for administering medications, intravenous fluids, nutrition solutions, and blood products, commonly employed in chemotherapy for cancer patients.

In the world of antibiotics, Bactrim (sulfamethoxazole-trimethoprim) stands as a powerful weapon against bacterial infections. It works greatt. This combination medication, composed of two active ingredients, has saved countless lives by combating a wide range of bacterial invaders.

However, beneath its lifesaving capabilities, Bactrim hides a potential complication – its role in contributing to yeast infections. In this comprehensive article, we delve into the mechanisms of Bactrim, the enigma of yeast infections (Candidiasis), and how the two intersect, shedding light on an often-overlooked aspect of antibiotic treatment.

Bactrim